Novo Nordisk reports positive data for oral semaglutide
Novo Nordisk’s oral semaglutide is an investigational glucagon-like peptide-1 analogue. Credit: Novo Nordisk A/S.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more